Breast Cancer Clinical Trials

Showing 181-200 of 4,817 trials

Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

NCT02422498

The study is being done to find out if the results of a pre-treatment biopsy can predict response to cisplatin and radiation treatment for patients with metastatic or recurrent triple negative breast cancer.

Locally Recurrent/Metastatic Triple Negative Breast Cancer

Memorial Sloan Kettering Cancer Center49 participantsStarted Apr 2015

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

RECRUITINGPhase 2

ctDNA in HER2+ EBC Neoadjuvant Treatment

NCT07335081

This study is a randomized, open-label, multicenter clinical study for patients with early or locally advanced (T≥2cm, N0-3, M0) HER2-positive breast cancer, aiming to compare the peripheral blood ctDNA clearance of neoadjuvant pyrotinib + trastuzumab + docetaxel and pertuzumab + trastuzumab + docetaxel for one course and to evaluate the therapeutic effectiveness of four courses of neoadjuvant therapy

Breast Cancer

Shanghai Jiao Tong University School of Medicine60 participantsStarted Feb 2024

Shanghai, China

Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

ctDNA in HER2+ EBC Neoadjuvant Treatment

Related Searches

Robotic Nipple-Sparing Mastectomy Vs Conventional Open Technique

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness.

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

Hypofractionated Online Adaptive Radiotherapy of Breast Cancer

Harvesting Cells for Experimental Cancer Treatments

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia

Study on the Level of Physical Activity in Patients Diagnosed With Breast Cancer in Spain

Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%